Cargando…
Cancer therapy with decreased SARS-CoV-2 infection rates in cancer patients
Autores principales: | Hayashi, Takuma, Konishi, Ikuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8717053/ https://www.ncbi.nlm.nih.gov/pubmed/34969997 http://dx.doi.org/10.1038/s41416-021-01685-3 |
Ejemplares similares
-
Possibility of SARS-CoV-2 Infection in the Metastatic Microenvironment of Cancer
por: Hayashi, Takuma, et al.
Publicado: (2022) -
Abstract 153: Examination of the affinity of anti-SARS-CoV-2 IgA, which is mucosal immunity, for SARS-CoV-2 BA.4 variant and BA.5 variant
por: Hayashi, Takuma, et al.
Publicado: (2023) -
Pathological Evidence for Residual SARS-CoV-2 in the Micrometastatic Niche of a Patient with Ovarian Cancer
por: Hayashi, Takuma, et al.
Publicado: (2022) -
Neuroinflammation triggered by SARS-CoV-2 infection: syndromes and therapies
por: Dale, Russell C, et al.
Publicado: (2021) -
Asymptomatic SARS-CoV-2 infection
por: Ooi, Eng Eong, et al.
Publicado: (2020)